Salveen Richter
Stock Analyst at Goldman Sachs
(3.41)
# 936
Out of 5,064 analysts
204
Total ratings
42.98%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $25.24 | -0.95% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $9.56 | +15.06% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $27.81 | +36.64% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $22.05 | -27.44% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $76.09 | -14.57% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $19.61 | -8.21% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $18.53 | +40.31% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $436.38 | +29.70% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $10.84 | +250.55% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $17.69 | +7.41% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $23.56 | -27.84% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $21.74 | +70.19% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $50.23 | -6.43% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $54.69 | +90.16% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $16.19 | +153.24% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $18.61 | -46.27% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $755.90 | +6.36% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $175.30 | +12.38% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $6.77 | +165.88% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $126.64 | -24.19% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $23.72 | +115.01% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $18.00 | +122.22% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $8.21 | +46.16% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $102.06 | -31.41% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $33.59 | +126.26% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $337.54 | +3.69% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $426.76 | +30.99% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $27.98 | -82.13% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.23 | +2,420.33% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $290.80 | -22.63% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.63 | +506.06% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.13 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.00 | +500.00% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.17 | +115.83% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.19 | -28.40% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.29 | +82.37% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $64.70 | -33.54% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.69 | -57.36% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $13.68 | +630.99% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $7.74 | +7,656.95% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $102.99 | -51.45% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $40.45 | +11.25% | 1 | Mar 17, 2020 |
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $25.24
Upside: -0.95%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $9.56
Upside: +15.06%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $27.81
Upside: +36.64%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $22.05
Upside: -27.44%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $76.09
Upside: -14.57%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $19.61
Upside: -8.21%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $18.53
Upside: +40.31%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $436.38
Upside: +29.70%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $10.84
Upside: +250.55%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $17.69
Upside: +7.41%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $23.56
Upside: -27.84%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $21.74
Upside: +70.19%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $50.23
Upside: -6.43%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $54.69
Upside: +90.16%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $16.19
Upside: +153.24%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $18.61
Upside: -46.27%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $755.90
Upside: +6.36%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $175.30
Upside: +12.38%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $6.77
Upside: +165.88%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $126.64
Upside: -24.19%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $23.72
Upside: +115.01%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $18.00
Upside: +122.22%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $8.21
Upside: +46.16%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $102.06
Upside: -31.41%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $33.59
Upside: +126.26%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $337.54
Upside: +3.69%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $426.76
Upside: +30.99%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $27.98
Upside: -82.13%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.23
Upside: +2,420.33%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $290.80
Upside: -22.63%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.63
Upside: +506.06%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $19.13
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $5.00
Upside: +500.00%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.17
Upside: +115.83%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.19
Upside: -28.40%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.29
Upside: +82.37%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $64.70
Upside: -33.54%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.69
Upside: -57.36%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $13.68
Upside: +630.99%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $7.74
Upside: +7,656.95%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $102.99
Upside: -51.45%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $40.45
Upside: +11.25%